| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K44224150 |
| PharmacoGx | BRD-K44224150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MITF | CTRPv2 | pan-cancer | AAC | 0.17 | 0.05 |
| mRNA | TUFT1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | RP11-321N4.5 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | DALRD3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | RANGRF | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | C11orf42 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | WDR41 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | OR6C75 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | CTD-2369P2.10 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | GGA3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
